Zhang Yu-ling, Zhou Shu-xian, Lei Juan, Yuan Gui-yi, Wang Jing-feng
Department of Cardiology, Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China.
Chin Med J (Engl). 2008 Nov 5;121(21):2192-6.
It has been reported that osteopontin has an important role in cardiac fibrosis and remodeling. However, its direct mechanisms remain unclear. The purpose of this study was to investigate the role of angiotensin and aldosterone blockades in cardiac osteopontin expression associated with cardiac remodeling in myocardial infarcted (MI) rats.
Fifty SD rats that survived 24 hours after ligating left anterior descending coronary artery were randomly divided into three groups: MI-saline group (n = 15, 5 ml/d), MI-perindopril group (n = 18, perindopril 2 mgxkg(-1)d(-1)) and MI-spironolacton (n = 17, spironolacton 20 mgxkg(-1)xd(-1)). A sham operation group (n = 15) was selected as non-infarcted control. At 6 weeks after treatment, hemodynamic pararmeters and left ventricular function were measured with catheterization, interstitial fibrosis infiltration and cardiomyocyte diameters were evaluated histologically. Myocardium osteopontin protein expression level in the non-infarcted myocardium was detected by Western blotting.
No osteopontin protein was detected in the myocardium of sham-operation rats. High levels of osteopontin protein expression were detected in the MI-saline rats, but the levels were suppressed in the MI-perindopril and MI-spironolacton rats at 6 weeks following MI (P < 0.01, respectively). Compared with the sham operation group, all rats in the MI group showed marked interstitial fibrosis infiltration in the non-infarction area, higher ventricular weight/body weight ratio, significantly increased cardiomyocyte diameter (P < 0.01, respectively), and developed significant systolic and diastolic dysfunction as indicated by decreased left ventricular systolic pressure (LVSP) and +/-dp/dt, as well as increased left ventricular end-diastolic pressure (LVEDP) (P < 0.01, respectively). Angiotensin and aldosterone blockades partly prevented cardiac fibrosis and systolic and diastolic dysfunction (P < 0.01, respectively).
Treatment with angiotensin and aldosterone blockades inhibits expression of osteopontin in the non-infarcted myocardium and prevents cardiac remodeling following MI.
据报道,骨桥蛋白在心脏纤维化和重塑中起重要作用。然而,其直接机制仍不清楚。本研究的目的是探讨血管紧张素和醛固酮阻断在心肌梗死(MI)大鼠心脏重塑相关的心脏骨桥蛋白表达中的作用。
将50只在结扎左冠状动脉前降支后存活24小时的SD大鼠随机分为三组:MI-生理盐水组(n = 15,5 ml/d)、MI-培哚普利组(n = 18,培哚普利2 mg·kg⁻¹·d⁻¹)和MI-螺内酯组(n = 17,螺内酯20 mg·kg⁻¹·d⁻¹)。选取假手术组(n = 15)作为未梗死对照。治疗6周后,通过导管插入术测量血流动力学参数和左心室功能,组织学评估间质纤维化浸润和心肌细胞直径。采用蛋白质印迹法检测非梗死心肌中骨桥蛋白的蛋白表达水平。
假手术大鼠心肌中未检测到骨桥蛋白。MI-生理盐水大鼠中检测到高水平的骨桥蛋白表达,但在MI后6周,MI-培哚普利和MI-螺内酯大鼠中的水平受到抑制(分别为P < 0.01)。与假手术组相比,MI组所有大鼠在非梗死区域均表现出明显的间质纤维化浸润、较高的心室重量/体重比、心肌细胞直径显著增加(分别为P < 0.01),并且出现明显的收缩和舒张功能障碍,表现为左心室收缩压(LVSP)和±dp/dt降低,以及左心室舒张末期压力(LVEDP)升高(分别为P < 0.01)。血管紧张素和醛固酮阻断部分预防了心脏纤维化以及收缩和舒张功能障碍(分别为P < 0.01)。
血管紧张素和醛固酮阻断治疗可抑制非梗死心肌中骨桥蛋白的表达,并预防MI后的心脏重塑。